![David Vaux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Vaux
Corporate Officer/Principal presso The Walter & Eliza Hall Institute of Medical Research
Posizioni attive di David Vaux
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | 08/08/2011 | - |
Storia della carriera di David Vaux
Formazione di David Vaux
University of Melbourne | Doctorate Degree |
Statistiche
Distribuzione geografica
Australia | 3 |
Posizioni
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
- Borsa valori
- Insiders
- David Vaux
- Esperienza